Nextage Therapeutics Valuation

MCTC Stock  ILA 37.70  1.30  3.33%   
At this time, the firm appears to be overvalued. Nextage Therapeutics secures a last-minute Real Value of 31.42 per share. The latest price of the firm is 37.7. Our model forecasts the value of Nextage Therapeutics from analyzing the firm fundamentals such as Operating Margin of (9.71) %, return on asset of -0.37, and Shares Owned By Insiders of 22.39 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
37.70
Please note that Nextage Therapeutics' price fluctuation is not too volatile at this time. Calculation of the real value of Nextage Therapeutics is based on 3 months time horizon. Increasing Nextage Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nextage Therapeutics is useful when determining the fair value of the Nextage stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nextage Therapeutics. Since Nextage Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nextage Stock. However, Nextage Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  37.7 Real  31.42 Hype  37.7
The real value of a stock, also known as the intrinsic value, is the underlying worth of a company that is reflected in its stock price. It is based on the company's financial performance, assets, liabilities, growth prospects, management team, industry conditions, and other relevant factors. The real value of a stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, price-to-book ratio, and other valuation metrics. The real value of a stock may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence the stock's price. It is important to note that the real value of a stock is not a fixed number and may change over time based on changes in the company's performance and other relevant factors.
31.42
Real Value
41.47
Upside
Estimating the potential upside or downside of Nextage Therapeutics helps investors to forecast how Nextage stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nextage Therapeutics more accurately as focusing exclusively on Nextage Therapeutics' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
31.9637.7043.44
Details

Nextage Therapeutics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Nextage Therapeutics's current stock value. Our valuation model uses many indicators to compare Nextage Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nextage Therapeutics competition to find correlations between indicators driving Nextage Therapeutics's intrinsic value. More Info.
Nextage Therapeutics is considered to be number one stock in net asset category among related companies. It is considered to be number one stock in price to sales category among related companies . The ratio of Net Asset to Price To Sales for Nextage Therapeutics is about  230,012 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nextage Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nextage Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nextage Therapeutics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nextage Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nextage Therapeutics and how it compares across the competition.

About Nextage Therapeutics Valuation

The stock valuation mechanism determines the current worth of Nextage Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nextage Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nextage Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Nextage Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nextage Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nextage Therapeutics. We calculate exposure to Nextage Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nextage Therapeutics's related companies.
Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide. Further, the company provides diagnostic solutions for multiple cancer diagnostic applications. MICROMEDIC TECHNOL operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange.

8 Steps to conduct Nextage Therapeutics' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nextage Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nextage Therapeutics' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Nextage Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Nextage Therapeutics' revenue streams: Identify Nextage Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Nextage Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Nextage Therapeutics' growth potential: Evaluate Nextage Therapeutics' management, business model, and growth potential.
  • Determine Nextage Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nextage Therapeutics' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Nextage Stock analysis

When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stocks Directory
Find actively traded stocks across global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Please note, there is a significant difference between Nextage Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nextage Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nextage Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.